Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abstract Background Methotrexate (MTX) remains the anchor drug in rheumatoid arthritis (RA) treatment, but is poorly tolerated or contraindicated in some patients. There is a wealth of data supporting the use of abatacept in combination with MTX, but data on alternative conventional synthetic diseas...

Full description

Bibliographic Details
Main Authors: Rieke Alten, Harald Burkhardt, Eugen Feist, Klaus Krüger, Juergen Rech, Andrea Rubbert-Roth, Reinhard E. Voll, Yedid Elbez, Christiane Rauch
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Arthritis Research & Therapy
Subjects:
Abatacept
Conventional synthetic disease-modifying antirheumatic drug
Azathioprine
Hydroxychloroquine
Leflunomide
Methotrexate
Online Access:http://link.springer.com/article/10.1186/s13075-017-1488-5

Internet

http://link.springer.com/article/10.1186/s13075-017-1488-5

Similar Items